GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $529,000 | -63.4% | 7,769 | -84.3% | 0.07% | -61.3% |
| Q4 2021 | $1,444,000 | -14.7% | 49,327 | -25.7% | 0.18% | +5.2% |
| Q3 2021 | $1,692,000 | +635.7% | 66,402 | +910.4% | 0.17% | +561.5% |
| Q2 2021 | $230,000 | -17.6% | 6,572 | +14.2% | 0.03% | -31.6% |
| Q3 2019 | $279,000 | +22.9% | 5,756 | +33.9% | 0.04% | +65.2% |
| Q1 2019 | $227,000 | +25.4% | 4,298 | -60.6% | 0.02% | +130.0% |
| Q2 2016 | $181,000 | – | 10,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |